Fertility preservation in women with cervical, endometrial or ovarian cancers.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27468354)

Published in Gynecol Oncol Res Pract on July 27, 2016

Authors

Michael Feichtinger1, Kenny A Rodriguez-Wallberg2

Author Affiliations

1: Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria ; Wunschbaby Institut Feichtinger, Vienna, Austria ; Department of Obstetrics and Gynecology, Section of Reproductive Medicine, Karolinska University Hospital, Novumhuset Plan 4, SE-141 86 Stockholm, Sweden.
2: Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden ; Department of Obstetrics and Gynecology, Section of Reproductive Medicine, Karolinska University Hospital, Novumhuset Plan 4, SE-141 86 Stockholm, Sweden.

Articles cited by this

(truncated to the top 100)

Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet (2006) 5.65

Endometrial cancer. Lancet (2005) 5.50

Livebirth after uterus transplantation. Lancet (2014) 5.14

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 3.92

Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol (2014) 2.67

Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst (2012) 2.49

Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report. Gynecol Oncol (2006) 2.23

Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ (2011) 2.21

Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril (2013) 2.12

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol (2009) 2.03

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol (2009) 2.02

Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG (2006) 1.84

Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol (2006) 1.78

Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76

Management of ovarian germ cell tumors. J Clin Oncol (2007) 1.76

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol (2007) 1.66

Radical trachelectomy versus radical hysterectomy for the treatment of early cervical cancer: a systematic review. Acta Obstet Gynecol Scand (2011) 1.57

Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol (1999) 1.56

Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys (2009) 1.56

Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol (2010) 1.55

Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer (2008) 1.54

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril (2008) 1.53

Fertility preservation in women. Nat Rev Endocrinol (2013) 1.50

Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol (2012) 1.49

Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol (2001) 1.48

Sequential cervical length screening in pregnancies after loop excision of the transformation zone conisation: a retrospective analysis. BJOG (2013) 1.47

The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol (1995) 1.47

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol (2004) 1.42

Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates. BJOG (2015) 1.41

GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online (2010) 1.39

The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol (2011) 1.38

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol (2012) 1.38

Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol (2007) 1.30

Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet (2015) 1.25

Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol (2012) 1.23

Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol (2010) 1.23

Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril (2000) 1.18

A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol (2001) 1.18

Management of pregnancy after radical trachelectomy: case reports and systematic review of the literature. Am J Perinatol (2007) 1.15

Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril (2013) 1.14

Special issues in fertility preservation for gynecologic malignancies. Crit Rev Oncol Hematol (2015) 1.13

Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG (2005) 1.13

Germ cell tumors of the ovary. Cancer Treat Rev (2008) 1.12

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol (2012) 1.11

Malignant germ cell tumors of the ovary. Hum Pathol (1977) 1.11

Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique). Hum Reprod (2005) 1.11

Fertility-sparing options for early stage cervical cancer. Gynecol Oncol (2010) 1.11

Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol (2001) 1.10

Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy - a systematic literature review. Gynecol Oncol (2013) 1.08

Psychosocial distress in young cancer survivors. Semin Oncol Nurs (2009) 1.07

Age-specific ovarian cancer incidence rate patterns in the United States. Gynecol Oncol (2005) 1.05

Current approach to fertility preservation by embryo cryopreservation. Fertil Steril (2013) 1.03

Pure dysgerminoma of the ovary 35 years on: a single institutional experience. Gynecol Oncol (2010) 1.03

Ovarian immature teratoma: treatment and outcome in a single institutional cohort. Gynecol Oncol (2011) 1.02

Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer (2004) 1.02

Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer. Gynecol Oncol (2012) 1.01

Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update (2012) 1.00

Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis. Minerva Med (2009) 1.00

Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril (2009) 1.00

Excisional cone as fertility-sparing treatment in early-stage cervical cancer. Fertil Steril (2010) 1.00

Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod (2012) 0.99

Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract Oncol (2007) 0.99

Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol (2013) 0.98

Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. Fertil Steril (2008) 0.98

Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: is it possible? Hum Reprod (2011) 0.97

Full-term newborn after repeated ovarian tissue transplants in a patient treated for Ewing sarcoma by sterilizing pelvic irradiation and chemotherapy. Acta Obstet Gynecol Scand (2015) 0.96

Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril (1998) 0.96

Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol (2011) 0.96

Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol (2010) 0.95

Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. Gynecol Oncol (2011) 0.94

Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am J Obstet Gynecol (1999) 0.94

Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol (2006) 0.93

Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol (2008) 0.93

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Gynecol Oncol (2011) 0.92

Fertility-sparing surgery in early epithelial ovarian cancer: a viable option? Obstet Gynecol Int (2012) 0.92

Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol (2013) 0.92

Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant (1998) 0.91

Long-term safety of fertility sparing surgery in early stage ovarian cancer: comparison to standard radical surgical procedures. Gynecol Oncol (2015) 0.90

Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol (2008) 0.90

Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol (2013) 0.90

LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Hum Reprod (2013) 0.90

Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer. Oncologist (2012) 0.89

Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril (2007) 0.89

Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary. Ann Oncol (2013) 0.88

Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). Gynecol Oncol (2010) 0.88

Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study. Gynecol Oncol (2007) 0.87

Obstetric outcomes of patients undergoing total laparoscopic radical trachelectomy for early stage cervical cancer. Gynecol Oncol (2013) 0.87

Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest (2010) 0.86

Fertility preservation during cancer treatment: clinical guidelines. Cancer Manag Res (2014) 0.86

Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. Eur J Cancer (2015) 0.86

Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study. Int J Gynecol Cancer (2011) 0.85

Clinical aspects of fertility preservation in female patients. Pediatr Blood Cancer (2009) 0.84

Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up. Hum Reprod (2013) 0.84

Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice. Gynecol Oncol (2009) 0.84

Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience. Gynecol Oncol (2011) 0.83

Reproductive choices and outcomes after freezing oocytes for medical reasons: a follow-up study. Hum Reprod (2014) 0.83

Successful in vitro fertilization pregnancy after conservative management of endometrial cancer. Fertil Steril (2001) 0.82

Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2cm or larger: A literature review and analysis of oncological and obstetrical outcomes. Gynecol Oncol (2015) 0.82

Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours. Hum Reprod (2006) 0.82